Displaying drugs 14701 - 14725 of 14838 in total
2-(N-morpholino)ethanesulfonic acid
Experimental
PF-04447943
PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational
Bioymifi
Bioymifi is a small molecule that acts as a tumor necrosis factor-related apoptosis-induced ligand (TRAIL) mimetic. Upon binding to the death receptor 5 (DR5) on cancer cells, bioymifi triggers apoptosis, possibly through a caspase-dependent pathway. Bioymifi is currently being investigated as an anti-tumor agent.[A257048,A257053]
Investigational
2-Nitro-4-cresol
Experimental
Benzoctamine
Benzoctamine is a drug with two main uses. It can be used as a sedative which does not depress the respiratory system, but rather stimulates it. It can also be used as an anxiolytic with the same efficacy as chlordiazepoxide for treating anxiety neurosis.
Experimental
IMIDAZOPYRIDAZIN 1
Experimental
9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE
Experimental
L-1-naphthyl-2-acetamido-ethane boronic acid
Experimental
6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE
Experimental
ING-1
ING-1 is a high-affinity, human engineered trade mark monoclonal antibody that recognizes a 40 kilodalton epithelial cell adhesion molecule (EpCAM) glycoprotein that is expressed in high levels on most adenocarcinomas. It is an attractive target for immunotherapy.
Investigational
Amitifadine
Investigational
Fluoresceinylthioureido
Experimental
FR230513
Experimental
2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate
Experimental
Patidegib
Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.
Investigational
Displaying drugs 14701 - 14725 of 14838 in total